We sat down with Dan Murphy and Dr. Jeffrey Lazarus to discuss the work that needs to be done to meet the United Nations' (U.N.) goal of ending the HIV epidemic by 2030 and to fully meet the needs of people living with HIV around the world.
Many of the communities who could most benefit from pre-exposure prophylaxis (PrEP) for HIV prevention haven’t been included in clinical trial design and execution over the years – but Gilead’s PURPOSE studies made their inclusion a primary goal.
As a way to support those impacted by Monday’s devastating earthquake in Türkiye and Syria, the Gilead Foundation is donating $1 million for on-the-ground relief efforts.
See, Vice President of Oncology Clinical Development at Gilead, took a moment to walk us through some of the new innovations in breast cancer and the work underway at Gilead Oncology, where the vision is to help bring more life to people with cancer.
As Gilead maps out its next decade, including plans for a new Research Center in Foster City, we talked with Flavius about Gilead’s history of innovation and plans for the future.
This year, she implemented a plan to remedy that – and with the support of a Gilead TRANScend grant, the Transinclusive Group opened a peer-run seven-bed housing program called CHOICES.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...